PDF herunterladen
Am J Perinatol 1998; 15(4): 229-232
DOI: 10.1055/s-2007-993932
ORIGINAL ARTICLE

© 1998 by Thieme Medical Publishers, Inc.

Ascertainment of 68,XX Double Aneuploidy by Midtrimester Biochemical Screening: A Case Report

Elaine L. Ross1 , James A. Bofill1 , Ray E. Shenefelt2 , Cheng W. Yu3 , Kenneth G. Perry1  Jr. 
  • 1Departments of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, Mississippi
  • 2Departments of Pathology, University of Mississippi Medical Center, Jackson, Mississippi
  • 3Departments of Preventive Medicine, University of Mississippi Medical Center, Jackson, Mississippi
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. März 2008 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

A fetus with 68,XX karyotype was ascertained by an elevated midtrimester MSHCG. By antenatal ultrasound, the only unusual finding was in relation to the placenta. Preterm delivery was mandated by the development of severe preeclampsia. Postmortem examination of the stillborn fetus demonstrated no abnormal physical findings other than bilateral syndactyly of fingers and toes.

Keywords

Biochemical screening - double aneuploidy - triploidy - 68,XX